WallStreetZenWallStreetZen

NYSE: EW
Edwards Lifesciences Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Edwards Lifesciences revenue was $5.87B for the trailing 12 months ending Sep 30, 2024, with 195.3% growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $1.4B, down 2.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, EW annual revenue was $6.0B, with 11.6% growth year-over-year.

EW past revenue growth

How has EW's revenue growth performed historically?

Company
9.83%
Industry
11.24%
Market
37.5%
EW's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
EW's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
EW's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

EW revenue history

Current Revenue
$5.9B
Current Earnings
$4.2B
Current Profit Margin
70.8%
EW's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when EW announces revenue.

EW Revenue History By Year

EW Yearly RevenueEW RevenueEW ChangeEW Revenue Growth
2023-12-31$6.00B$622.40M+11.56%
2022-12-31$5.38B$149.90M+2.86%
2021-12-31$5.23B$846.20M+19.29%
2020-12-31$4.39B$38.30M+0.88%
2019-12-31$4.35B$625.20M+16.79%
2018-12-31$3.72B$287.50M+8.37%
2017-12-31$3.44B$471.60M+15.91%
2016-12-31$2.96B$470.00M+18.85%
2015-12-31$2.49B$170.80M+7.35%
2014-12-31$2.32B$277.40M+13.56%
2013-12-31$2.05B$145.90M+7.68%
2012-12-31$1.90B$221.00M+13.17%
2011-12-31$1.68B$231.60M+16.01%
2010-12-31$1.45B$125.60M+9.51%
2009-12-31$1.32B$83.70M+6.76%
2008-12-31$1.24B$146.60M+13.44%
2007-12-31$1.09B$54.10M+5.22%
2006-12-31$1.04B$39.10M+3.92%
2005-12-31$997.90M$66.40M+7.13%
2004-12-31$931.50M$71.00M+8.25%
2003-12-31$860.50M$156.50M+22.23%
2002-12-31$704.00M$11.90M+1.72%
2001-12-31$692.10M-$111.70M-13.90%
2000-12-31$803.80M-$101.20M-11.18%
1999-12-31$905.00M$40.00M+4.62%
1998-12-31$865.00M-$14.00M-1.59%
1997-12-31$879.00M$42.00M+5.02%
1996-12-31$837.00MN/AN/A

1 of 2

Edwards Lifesciences Revenue FAQ

What was EW's revenue last quarter?

On Invalid Date, Edwards Lifesciences (NYSE: EW) reported Q3 2024 revenue of $1.35 billion up 8.93% year over year. In the same quarter last year, Edwards Lifesciences's revenue was $1.24 billion.

What was Edwards Lifesciences's revenue in 2023?

Edwards Lifesciences's annual revenue for the twelve months ending Dec 31, 2023 was $6.00 billion, a 11.56% increase year over year.

How much does Edwards Lifesciences make in a day?

Based on Edwards Lifesciences annual revenue for the past five years, EW makes an average of $13,892,602.74 per day.

What was Edwards Lifesciences's annual revenue growth in the past year?

As of Q4 2024, Edwards Lifesciences's revenue has grown 9.83% year over year. This is 1.4 percentage points lower than the US Medical Devices industry revenue growth rate of 11.24%. Edwards Lifesciences's revenue in the past year totaled $5.87 billion.

How much does Edwards Lifesciences make in a year?

Edwards Lifesciences's revenue by year for the past five years is:
  • Edwards Lifesciences's revenue for the twelve months ending Dec 31, 2023 was $6.00 billion, a 11.56% increase year over year.
  • Edwards Lifesciences's annual revenue for Dec 31, 2022 was $5.38 billion, a 2.86% increase from 2021.
  • Edwards Lifesciences's annual revenue for 2021 was $5.23 billion, a 19.29% increase from 2020.
  • Edwards Lifesciences's annual revenue for 2020 was $4.39 billion, a 0.88% increase from 2019.
  • Edwards Lifesciences's annual revenue for 2019 was $4.35 billion, a 16.79% increase from 2018.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.